Suppr超能文献

2020 年 8 月,印度尼西亚对 COVID-19 大流行反应的首次行动审查。

The First Intra-Action Review of Indonesia's Response to the COVID-19 Pandemic, August 2020.

机构信息

Endang Widuri Wulandari, MD, MEpid, is a National Professional Officer, WHO Health Emergency Programme, Indonesia Country Office, World Health Organization, Jakarta, Indonesia. Endang Budi Hastuti, MD, is Emerging Infectious Diseases Programme Coordinator and Vensya Sitohang, DMD, MEpid, is Director of Environmental Health; both in the Directorate General of Disease Prevention and Control, Ministry of Health, Jakarta, Indonesia. Vivi Setiawaty, MD, MBiomed, is Head, Centre of Biomedical and Basic Health Technology, National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia. Sudarto Ronoatmodjo, MD, SKM, MSc, is a Lecturer, Department Epidemiology, Faculty of Public Health, University of Indonesia, Depok, West Java, Indonesia. The authors alone are responsible for the views expressed in this article. They do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

出版信息

Health Secur. 2021 Sep-Oct;19(5):521-531. doi: 10.1089/hs.2021.0071. Epub 2021 Sep 27.

Abstract

The COVID-19 pandemic has had an unprecedented impact on health, society, and the economy globally and in Indonesia. The World Health Organization (WHO) recommended the use of intra-action reviews (IARs) to identify best practices, gaps, and lessons learned to make real-time improvements to the COVID-19 response. The Emergency Committee of the International Health Regulations (2005) has recommended that countries share COVID-19 best practices and lessons learned with peer countries through IARs. Using WHO-established methodology, we conducted the first IAR of Indonesia's COVID-19 response from January through August 2020. The review covered 10 thematic areas (pillars): (1) command and coordination; (2) operational support and logistics; (3) surveillance, rapid response teams, risk assessment, and field investigation; (4) laboratories; (5) case management; (6) infection prevention and control; (7) risk communication and community empowerment; (8) points of entry, international travel, and transportation; (9) large-scale social restrictions; and (10) maintaining essential health services and systems. We held focus group discussions with a variety of stakeholders from a range of government departments, provincial health offices, and nongovernmental organizations. We used the results of the focus group discussions and other key findings from the IAR to formulate recommendations. The IAR identified key areas for improvement at national and subnational levels across all 10 pillars. Priority recommendations included improving multisectoral coordination and monitoring of COVID-19 response plan indicators; strengthening implementation of public health response measures, including case detection, isolation, infection prevention and control, contact tracing, and quarantine; and improving data collection, analysis, and reporting to inform public health risk assessment and response. The IAR is a useful tool for reviewing progress and identifying areas to improve the COVID-19 response in real time and provides a means to share information on areas of need with COVID-19 response partners and contributes to International Health Regulations (2005) core capacity development.

摘要

新型冠状病毒病大流行对全球和印度尼西亚的卫生、社会和经济造成了前所未有的影响。世界卫生组织(世卫组织)建议使用行动中审查(IAR)来确定最佳做法、差距和经验教训,以便实时改进对新冠病毒病的应对。国际卫生条例(2005 年)突发事件委员会建议各国通过 IAR 与同行国家分享新冠病毒病最佳做法和经验教训。我们使用世卫组织制定的方法,于 2020 年 1 月至 8 月对印度尼西亚的新冠病毒病应对措施进行了首次 IAR。审查涵盖了 10 个专题领域(支柱):(1)指挥和协调;(2)业务支持和后勤;(3)监测、快速反应小组、风险评估和现场调查;(4)实验室;(5)病例管理;(6)感染预防和控制;(7)风险沟通和社区赋权;(8)入境点、国际旅行和运输;(9)大规模社会限制;和(10)维持基本卫生服务和系统。我们与来自政府各部门、省级卫生办公室和非政府组织的各种利益攸关方举行了焦点小组讨论。我们使用焦点小组讨论的结果和 IAR 的其他重要发现来制定建议。IAR 在所有 10 个支柱的国家和国家以下各级确定了改进的重点领域。优先建议包括改善多部门协调和监测新冠病毒病应对计划指标;加强公共卫生应对措施的实施,包括病例发现、隔离、感染预防和控制、接触者追踪和检疫;以及改善数据收集、分析和报告,以进行公共卫生风险评估和应对。IAR 是审查进展情况和实时确定改进新冠病毒病应对措施的重点领域的有用工具,并为与新冠病毒病应对伙伴分享需求领域的信息提供了一种手段,有助于国际卫生条例(2005 年)核心能力发展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验